Item(by='notafraudster', descendants=None, kids=None, score=None, time=1611049417, title=None, item_type='comment', url=None, parent=25831515, text='Agreed with your push-back on the sample size thing being operative (this is a point I&#x27;ve made frequently on HN study threads), and agree that the primary design consideration is the post-&quot;treatment&quot; measurement of the outcome making it more likely that having an autistic kid changes metabolites than that having different metabolites influences chance of having an autistic kid.<p>Still, even with contemporaneous measurement, my guess is that there&#x27;d be a very real selection issue here; a non-random subset of people who could receive an autism diagnosis do, and to the extent the confounders into diagnosis (one presumes all the standard SES&#x2F;race&#x2F;access to healthcare factors are confounders here) constitutes a selection on the dependent variable, even a contemporaneous sample would not generalize to the population of interest.')